CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /FinVector
    FinVector logo

    FinVector

    Premium Partner
    CDMO
    Finland
    https://finvector.com/

    Is this your company? Claim this profile

    Drug Product
    Advanced Modalities
    Analytical & Bioanalytical Services
    Company Overview

    About

    FinVector is a pharmaceutical CDMO offering comprehensive services.

    Key Expertise

    Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals

    Therapeutic Areas

    Neurology
    Quick Facts
    HQ:Finland
    Founded:2018
    Employees:1,221
    Capabilities & Services

    Core Capabilities

    • Cytotoxic / ADC Handling
    • High-Potency API
    • Sterile Fill/Finish

    Types of Organization

    GMP Manufacturing
    Quality Systems
    Regulatory Support

    Dosage Forms

    Topical / Transdermal

    Containment Capabilities

    OEB 5 (≤1 µg/m³)
    Cytotoxic / ADC Handling

    Production Scales

    Phase II
    Clinical
    Pilot Scale

    Markets Served

    Asia-Pacific
    Manufacturing Facilities

    1 site worldwide

    FinVector Oy

    Microkatu 1S, Kuopio, 70210
    View on Map

    Site Capabilities

    4 capabilities
    ANALYSIS
    LABEL
    MANUFACTURE
    PACK
    International Regulatory
    EU GMP Certificates
    4
    Regulatory Bodies
    EMA/EudraGMDP
    Regulatory Approvals
    Drug Approval LEU8EZ
    EMA · #APR-PW0C87AF · 2019-02-01
    Drug Approval UISOUB
    EMA · #APR-NOY3TB1Z · 2021-06-01

    Case Studies

    0 published case studies showcasing past projects, challenges and outcomes.

    Certifications

    FDA Registration

    U.S. Food and Drug Administration
    Cert #: CERT-EP991IHF
    Issued: 2020-07-13
    Expires: 2025-03-22

    ISO 9001:2015

    International Organization for Standardization
    Cert #: CERT-TJY1NDRF
    Issued: 2020-01-07
    Expires: 2025-09-07

    ISO 13485:2016

    International Organization for Standardization
    Cert #: CERT-AKSPY0X9
    Issued: 2020-01-24
    Expires: 2025-06-17

    MHRA GMP

    UK Medicines and Healthcare products Regulatory Agency
    Cert #: CERT-4Z583S2S
    Issued: 2020-07-12
    Expires: 2025-09-25
    Loading CDMO intelligence...
    Request an Introduction

    Please log in to contact this provider.

    Key facts about FinVector

    • FinVector is headquartered in Finland.
    • FinVector was founded in 2018.
    • FinVector has 1,221 employees.
    • FinVector has one manufacturing site listed on CDMO Hub, in Kuopio, Finland.
    • FinVector's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.

    Find CDMOs like FinVector

    Directory pages this company appears in, each with the full list of matching manufacturers.

    Fill-Finish CDMOsTopical / Transdermal CDMOsOEB 5 (≤1 µg/m³) CDMOsCytotoxic / ADC Handling CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA